<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD08820000_1</Organism_ID>
  <Organism>Mouse</Organism>
  <Organism_Latin>Mus musculus</Organism_Latin>
  <UniProt_ID>Q03526</UniProt_ID>
  <Seq_Length>625</Seq_Length>
  <Molecule_Weight>72292</Molecule_Weight>
  <KEGG_ID>mmu:16428</KEGG_ID>
  <Orthology_ID>K07363</Orthology_ID>
  <Function_Summary>Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T-cells and nonconventional NKT-cells. When antigen presenting cells (APC) activate T-cell receptor (TCR), a series of phosphorylation lead to the recruitment of ITK to the cell membrane, in the vicinity of the stimulated TCR receptor, where it is phosphorylated by LCK. Phosphorylation leads to ITK autophosphorylation and full activation. Once activated, phosphorylates PLCG1, leading to the activation of this lipase and subsequent cleavage of its substrates. In turn, the endoplasmic reticulum releases calcium in the cytoplasm and the nuclear activator of activated T-cells (NFAT) translocates into the nucleus to perform its transcriptional duty. Phosphorylates 2 essential adapter proteins: the linker for activation of T-cells/LAT protein and LCP2. Then, a large number of signaling molecules such as VAV1 are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation.</Function_Summary>
  <Catalytic_Mechanism>ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF00779:BTK@@PF00169:PH@@PF07714:Pkinase_Tyr@@PF00017:SH2@@PF00018:SH3_1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>5</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>T-cell-specific kinase</Alias>
      <Alias>Kinase TLK</Alias>
      <Alias>Kinase EMT</Alias>
      <Alias>IL-2-inducible T-cell kinase</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase activity</Keyword>
      <Ontology_ID>GO:0016301</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + a non-membrane spanning protein L-tyrosine = ADP + a non-membrane spanning protein L-tyrosine phosphate.</Detail>
      <Keyword>Non-membrane spanning protein tyrosine kinase activity</Keyword>
      <Ontology_ID>GO:0004715</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.</Detail>
      <Keyword>Protein tyrosine kinase activity</Keyword>
      <Ontology_ID>GO:0004713</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with phospholipids, a class of lipids containing phosphoric acid as a mono- or diester.</Detail>
      <Keyword>Phospholipid binding</Keyword>
      <Ontology_ID>GO:0005543</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The appearance of interleukin-4 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.</Detail>
      <Keyword>Interleukin-4 production</Keyword>
      <Ontology_ID>GO:0032633</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.</Detail>
      <Keyword>Intracellular signal transduction</Keyword>
      <Ontology_ID>GO:0035556</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in immunity, any immune system process that functions in the response of an organism to a potential internal or invasive threat. The vertebrate immune system is formed by the innate immune system (composed of phagocytes, complement, antimicrobial peptides, etc) and by the adaptive immune system which consists of T- and B-lymphocytes.</Detail>
      <Keyword>Immunity</Keyword>
      <Ontology_ID>KW-0391</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>An immune response based on directed amplification of specific receptors for antigen produced through a somatic diversification process, and allowing for enhanced response to subsequent exposures to the same antigen (immunological memory).</Detail>
      <Keyword>Adaptive immune response</Keyword>
      <Ontology_ID>GO:0002250</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.</Detail>
      <Keyword>T cell receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0050852</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The appearance of interferon-gamma due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Interferon-gamma is also known as type II interferon.</Detail>
      <Keyword>Interferon-gamma production</Keyword>
      <Ontology_ID>GO:0032609</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The initiation of the activity of the inactive enzyme phospolipase C as the result of a series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>Activation of phospholipase C activity</Keyword>
      <Ontology_ID>GO:0007202</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in adaptive immunity. Vertebrates can develop a broad and almost infinite repertoire of antigen-specific receptors, which allows vertebrates to recognize almost any potential pathogen or toxin and to mount antigen-specific responses to it. Two types of adaptive immunity systems have evolved in vertebrates in order to generate immune receptor diversity. The jawed vertebrates strategy uses the V(D)JC recombination to achieve combinatorial diversity of immunoglobulin-based B cell receptors and T cell receptors. The jawless vertebrate strategy uses the somatic rearrangements of variable leucine-rich cassettes in the variable lymphocyte receptors (VLRs). The hallmarks of an adaptive immune system is the production of antigen-specific recognition receptor by somatic gene rearrangement. The long life of some antigen-primed cytotoxic lymphocytes and plasma cells provide protective memory to prevent reinvasion.</Detail>
      <Keyword>Adaptive immunity</Keyword>
      <Ontology_ID>KW-1064</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which a precursor cell type acquires the specialized features of a NK T cell.</Detail>
      <Keyword>NK T cell differentiation</Keyword>
      <Ontology_ID>GO:0001865</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>186</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>570</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>301</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>517</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MNNFILLEEQLIKKSQQKRRTSPSNFKVRFFVLTKASLAYFEDRHGKKRTLKGSIELSRIKCVEIVKSDISIPCHYKYPFQTLVYLQVVHDNYLLYVFAPDCESRQRWVLTLKEETRNNNSLVSKYHPNFWMDGRWRCCSQLEKPAVGCAPYDPSKNASKKPLPPTPEDNRRSFQEPEETLVIALYDYQTNDPQELALRCDEEYYLLDSSEIHWWRVQDKNGHEGYAPSSYLVEKSPNNLETYEWYNKSISRDKAEKLLLDTGKEGAFMVRDSRTPGTYTVSVFTKAIISENPCIKHYHIKETNDSPKRYYVAEKYVFDSIPLLIQYHQYNGGGLVTRLRYPVCSWRQKAPVTAGLRYGKWVIQPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIQEGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRSQRGLFAAETLLGMCLDVCEGMAYLEKACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASCHVYQIMNHCWKEKPEDRPPFSQLLSQLAEIAEAGL</Protein_Seq>
    <DNA_Seq>GACTCTCTAAAGATCAACTGCATCCTGTCTCAGTCTCCGCTGCTCCTCTCCTTCAGTCGCACTGCGGGGTGATGCCCAAGGCGCATCACTTTTCAGAACTGGACCATGAACAACTTCATCCTCCTGGAAGAACAGCTGATCAAGAAGTCCCAACAGAAGAGAAGGACTTCTCCCTCGAATTTTAAAGTTCGTTTCTTTGTCTTAACGAAAGCCAGCCTGGCCTACTTTGAGGACCGCCACGGGAAGAAGCGCACGTTGAAGGGCTCCATTGAACTCTCCAGAATCAAGTGTGTGGAGATTGTCAAGAGTGACATTAGCATCCCGTGCCACTATAAATACCCTTTTCAGGTCGTGCATGACAACTATCTCCTGTATGTGTTTGCTCCAGACTGTGAGAGTCGGCAGCGCTGGGTGCTGACCCTTAAAGAAGAAACGAGGAATAACAACAGCCTGGTATCCAAGTATCACCCTAATTTCTGGATGGATGGGCGGTGGAGGTGCTGCTCCCAGCTGGAGAAGCCTGCTGTAGGCTGTGCTCCCTACGACCCATCCAAGAATGCTTCAAAGAAGCCTCTTCCTCCTACTCCTGAAGACAACAGGCGGTCATTTCAGGAACCTGAAGAAACCCTGGTCATTGCCTTGTACGACTACCAAACCAACGACCCTCAGGAGCTCGCACTGCGGTGTGATGAAGAGTACTACCTGCTGGACAGCTCCGAGATCCACTGGTGGAGGGTTCAAGACAAAAATGGGCATGAAGGATATGCACCAAGCAGTTACCTGGTAGAAAAATCTCCAAATAACCTTGAAACCTATGAGTGGTACAATAAAAGCATCAGCCGCGACAAAGCTGAAAAACTTCTTTTGGACACAGGTAAAGAAGGAGCTTTCATGGTCCGAGATTCCAGGACACCCGGGACATACACAGTCTCTGTTTTCACCAAGGCCATCATAAGTGAGAACCCCTGTATAAAACATTATCACATCAAAGAAACAAATGACAGCCCCAAGCGCTACTACGTGGCTGAGAAGTATGTGTTTGACTCCATCCCTCTCCTCATCCAGTATCACCAGTACAATGGAGGAGGTTTGGTCACTCGACTCCGCTATCCAGTTTGCTCCTGGAGACAAAAAGCCCCTGTCACAGCAGGGCTAAGATATGGGAAGTGGGTGATCCAACCCTCAGAGCTAACGTTCGTGCAGGAGATTGGCAGCGGGCAGTTTGGGCTGGTGCATCTCGGCTACTGGCTCAACAAGGACAAGGTGGCCATCAAGACCATTCAGGAAGGGGCGATGTCAGAAGAAGACTTTATCGAGGAGGCGGAAGTCATGATGAAACTCTCTCACCCCAAACTGGTGCAGCTCTATGGGGTGTGCCTGGAGCAAGCCCCCATCTGCCTGGTGTTTGAGTTCATGGAGCACGGCTGCCTGTCGGATTACCTTCGAAGTCAGCGGGGTCTCTTTGCTGCGGAGACCCTGCTGGGCATGTGCCTGGATGTGTGTGAGGGCATGGCCTACCTGGAAAAAGCTTGTGTCATCCACAGAGACCTGGCAGCCAGAAACTGTTTGGTGGGAGAAAACCAGGTCATCAAGGTGTCCGACTTTGGGATGACAAGATTTGTCCTTGATGATCAATATACCAGCTCCACGGGCACCAAATTCCCAGTGAAGTGGGCATCCCCAGAGGTGTTCTCCTTTAGTCGCTATAGCAGCAAGTCAGATGTGTGGTCGTTTGGTGTACTGATGTGGGAAGTCTTCAGTGAAGGCAAAATCCCATACGAAAACCGAAGCAATTCCGAGGTCGTGGAAGATATCAGCACTGGCTTTCGGTTATACAAGCCCCGCCTGGCCTCCTGTCATGTCTACCAGATCATGAATCATTGCTGGAAAGAGAAACCAGAAGACCGGCCACCCTTCTCCCAGCTGTTAAGCCAGCTGGCTGAAATCGCAGAAGCTGGGCTTTAGCAGGGACTCATTGACCAGACACAGCCATAAATCCTGAGTGAAGGAACAATGTCCTTTTTCCAGAGCATTAAAAGCTGCCACCAGTCCAGAAACCCCCACAGGTGCCTGGACCATGGTGCCAGCACCTATGCAGCCACAACTGCAGCATCATAGAAAAGGGTGGAGGGCCGGCCACTGAGCCAACAGCTGAACCACAACTGGAGCAGTATCTGCGTGTCCACCCCATCCCAGCCTCTTGTCGTATGCTGTACTCAAAGCTCCATTGCCCACTCTCGGGAGCATCCCCTCCCCCTCTTAGCAATCAGGAGAGGCAGACGTAGGCCACACTCTTCTTTATTATTACTTTTAAGAATAATTCAAGTAACCTTTAATTTGGCCCAACGAGACATTGTGCCCATTTTATGGATGGAAGAGCGGGAAAGCATCATTCTTTTTCTAAGAAATGCAAGAGGTGATTAAACCAGGGTGTTCTACTACTTCAAGGCTGTCAGCCACAGCTTCCTGCCTCACATGAGGCGGAGCGGATGCTTGTGCCAGAGGCCGGATGCCATAAGGTTTCAGAGCACACTGCCACCTCTCTTTGATGGGGCACAGAGAGCTCCACCGGGTGGATAGGGCAGGGTGACACATTCAGACCCCACGGCAGGACCACAGGATGTCTGAGGTCGGTCAGGAATGAGAGGGCCTCTGATGGTGGAAGTAAAGAGCTGCAAAAGAAGCCTTTGGGTTGTCCCTGACCCAGCGGCCCTGTTTCACGGTGAGTCATGTGTGTGACTGGATCTCCTGTTCTGTGCAGGATGCTGAAGCAGTGACTACAGAACGGTCATCATTCCAGCCTCTCAGGAGCGGCATCCACTCAGCACTGTCATGATCCTTGTGACTTTGAGACTTTGGGTTCTTTCAAGCCTTTACGGGTTCAGCAGTCTTAAGGTTGCCATGTAAGGCTCTCAAGAGCCCAGCAAAGGAAGAAGGCGTTTGCTCTTGCCCAAACTATCAGGAAGGAAAGAGGCAAGCACTGGGCGGTGCTTCCAAAATGCACAGGATGTCTCCTACTGATTGGCACTCGCACAGGTGACATGTGTATATCCTGCACACAGGTCATCCCTGGCGAATCACAGTTCATACCAACCCAACCACGAGGTATTATTCATGTCTTACAGAAAGTGGACTTGGTCTTTTAAAAGCTGGATAGCTGCCCCAGTGACAGAACTGGGAAGGACGGAGATTGAGATGACACCCGAATATAACTCCAGTGTAGCCTCTTAGCTCTTCTCAATGCTGCCTCCTACTGAGGTTGGGCCGCTGAGCGCATAACACAGGAAAGTCTGGGTTAATGGGCACCCCACCCCACAGCCAAGTTGCTCCTACTCAGAGCACTGGGGGGCCCAGTGGGACCCTCCAAATTGAAATAGGCTGTTCTCTTTCTTCACCCTCACCTGGATCTGAGTTCACAACCCTGGAGCCACTCAAAATTAACCCTTTCATTCTCCCAACCTACCAGAGTCACATTGCCTGAGGCCATTTATACTAGAGCTTCAAAGGTGCTTTCAACTAGTCTCCTGCAGACTGTTTCCTGTAATTATCCCTTCAACCTAGAGCTGGCTCTCTTGTGAGAAGGAGGATTCCCTGGTGCCAGGCACACTGGATTTTCCTGCGGTGTTCAGACAAAGCCCCTAGAAAAATGATCAGAGTCACAGATCCCTCTTCCTAAGTCACGTGGCATTTAGGCTGGCTTGAGGCTCAAATGCATCACTTCCAACTGTAATCACTGTGTCCAGATAAAACTCTGTCATTCAGAAAATGAACTTCCTCAACTGGTCCACAATCATCTCTGTTTATTCTCTTTTGGGAAACCTTAATTAAGAGACGATTTCTGGGACATCCAATCTGGAAGATAAACACTGGAACCGAGAGAAGTCTGTGGTGTGGTTTAGGAGACTGGCCCCCATACGGTGGTATTGGCTCTCTTAACCTCACATGCACGAAGGCTTTGATGGACGCGTGTGCACTGCTTACTCCAGTGTCCTGCTTGGGAAGATGGGATTCTCTTCTGCTGGTTTCTGTCTTACATTTTTTTTGTAAATGGTGCCCTGTGTTCACAGAAAGGTTTTGGTTTGAAATGTATTTTGTAGGCCTTGCAATTCATAATGTTTGGAACTATGTATTTATGCCTAGATCAGGAGAGTATTTATTGCTTGTCTTCATGATAAAAAATACTGCAGGTATGTCTTACCCTCTGTGGGGGCCACAAGTCAATCATTGCTTATGGAAAAAAATATATATATAAAGCTACATGTTTTACAAGTAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>T-lymphocytes</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Spleen</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Thymus</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Natural killer cells</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Lymph node</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Mast cells</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>Itk</Gene_Name>
    <Gene_Alias>Emt; Tlk; Tsk</Gene_Alias>
    <Gene_ID>16428</Gene_ID>
    <Genbank_ACCN>NM_010583</Genbank_ACCN>
    <Protein_ACCN>NP_034713</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/16428</Gene_URL>
    <EMBL_ID>ENSMUSG00000020395</EMBL_ID>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>NMR Structure of the Itk SH2 domain, Pro287cis, Energy minimized average structure</PDB_Title>
      <PDB_ID>1LUK</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LUK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural characterization of a proline-driven conformational switch  within the Itk SH2 domain</PubMed_Title>
      <Author>Mallis, R.J., et al.</Author>
      <Journal>Nat.Struct.Biol.(2002)9:900-905</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12402030?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR Structures of Itk SH2 domain, Pro287cis isoform, ensemble of 20 low energy structures</PDB_Title>
      <PDB_ID>1LUI</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LUI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural characterization of a proline-driven conformational switch  within the Itk SH2 domain</PubMed_Title>
      <Author>Mallis, R.J., et al.</Author>
      <Journal>Nat.Struct.Biol.(2002)9:900-905</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12402030?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR Structure of the Itk SH2 domain, Pro287trans, energy minimized average structure</PDB_Title>
      <PDB_ID>1LUN</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LUN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural characterization of a proline-driven conformational switch  within the Itk SH2 domain</PubMed_Title>
      <Author>Mallis, R.J., et al.</Author>
      <Journal>Nat.Struct.Biol.(2002)9:900-905</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12402030?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR Structure of the Itk SH2 domain, Pro287trans, 20 low energy structures</PDB_Title>
      <PDB_ID>1LUM</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LUM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural characterization of a proline-driven conformational switch  within the Itk SH2 domain</PubMed_Title>
      <Author>Mallis, R.J., et al.</Author>
      <Journal>Nat.Struct.Biol.(2002)9:900-905</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12402030?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>INTRAMOLECULAR ITK-PROLINE COMPLEX, NMR, MINIMIZED AVERAGE STRUCTURE</PDB_Title>
      <PDB_ID>1AWJ</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1AWJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Regulatory intramolecular association in a tyrosine kinase of the Tec family.</PubMed_Title>
      <Author>Andreotti, A.H., et al.</Author>
      <Journal>Nature(1997)385:93-97</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8985255?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Ensemble Structures of the binary complex between the SH3 and SH2 domain of interleukin-2 tyrosine kinase.</PDB_Title>
      <PDB_ID>2K7A</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2K7A</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Proline Isomerization Preorganizes the Itk SH2 Domain for Binding to the Itk SH3 Domain</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Solution Structure of the binary complex between the SH3 and SH2 domain of interleukin-2 tyrosine kinase</PDB_Title>
      <PDB_ID>2K79</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2K79</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Proline Isomerization Preorganizes the Itk SH2 Domain for Binding to the Itk SH3 Domain</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>NMR structure note: murine Itk SH3 domain</PDB_Title>
      <PDB_ID>2RN8</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RN8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>NMR structure note: murine Itk SH3 domain</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the Itk SH2 domain.</PDB_Title>
      <PDB_ID>3S9K</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3S9K</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the interleukin-2 tyrosine kinase Src homology 2 domain; comparison between X-ray and NMR-derived structures.</PubMed_Title>
      <Author>Joseph, R.E., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.F(2012)68:145-153</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22297986?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Itk SH3 average minimized</PDB_Title>
      <PDB_ID>2RNA</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2RNA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>NMR structure note: murine Itk SH3 domain</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>The NMR minimized average structure of the Itk SH2 domain bound to a phosphopeptide</PDB_Title>
      <PDB_ID>2ETZ</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ETZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular Details of Itk Activation by Prolyl Isomerization and Phospholigand Binding: The NMR Structure of the Itk SH2 Domain Bound to a Phosphopeptide.</PubMed_Title>
      <Author>Pletneva, E.V., et al.</Author>
      <Journal>J.Mol.Biol.(2006)357:550-561</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16436281?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The NMR ensemble structure of the Itk SH2 domain bound to a phosphopeptide</PDB_Title>
      <PDB_ID>2EU0</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2EU0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular Details of Itk Activation by Prolyl Isomerization and Phospholigand Binding: The NMR Structure of the Itk SH2 Domain Bound to a Phosphopeptide.</PubMed_Title>
      <Author>Pletneva, E.V., et al.</Author>
      <Journal>J.Mol.Biol.(2006)357:550-561</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16436281?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04660</Pathway_ID>
      <Pathway_Title>T cell receptor signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04062</Pathway_ID>
      <Pathway_Title>Chemokine signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04670</Pathway_ID>
      <Pathway_Title>Leukocyte transendothelial migration</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.gc.c.b.j.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1awj</CATH_URL>
  </Fold>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.7.10.2</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/7/10/2.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD08820001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD08820002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD08820003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD08820004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD08820006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>